Clinical Trials Logo

Chronic Anal Fissure clinical trials

View clinical trials related to Chronic Anal Fissure.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05598164 Recruiting - Clinical trials for Chronic Anal Fissure

Botulinum Toxin Type A in the Treatment of Chronic Anal Fissure

BTATCAF
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

This study is aimed at studying the effectiveness and safety of surgical treatment of chronic anal fissure.

NCT ID: NCT05117697 Recruiting - Clinical trials for Chronic Anal Fissure

Surgical Treatment of a Chronic Anal Fissure

STCAF
Start date: November 1, 2021
Phase: N/A
Study type: Interventional

This study is aimed at studying the effectiveness and safety of surgical treatment of chronic anal fissure.

NCT ID: NCT03920449 Recruiting - Clinical trials for Chronic Anal Fissure

Postero-lateral Internal Sphincterotomy vs Botulinum Toxin Injection in the Treatment of Chronic Anal Fissure

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

We hypothesized that optimization of the dose of the Botulinum toxin injection (BT) and standardization of the technique of lateral internal sphincterotomy to posterolateral internal sphincterotomy (PIAS) could, in turn, report a conclusive result which helps to provide better care to patients with chronic anal fissure. So, we will conduct this trial as a prospective randomized, controlled, intervention, open-label trial with two parallel groups, and a primary endpoint of fissure healing during 6 months after the initial intervention, with the randomization, will be performed by an online software with a 1:1 allocation. Eligible patients will be randomized in equal proportions between BT injection and PIAS.